NCT00745446

Brief Summary

The purpose of this study is to determine whether a retrofit particle trap can reduce the adverse vascular responses to diesel exhaust inhalation

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
18

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2007

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2007

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2008

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2008

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

September 2, 2008

Completed
1 day until next milestone

First Posted

Study publicly available on registry

September 3, 2008

Completed
Last Updated

September 5, 2008

Status Verified

September 1, 2008

Enrollment Period

5 months

First QC Date

September 2, 2008

Last Update Submit

September 4, 2008

Conditions

Keywords

Air pollutionDiesel exhaustEndothelial functionVascular functionParticle trapThrombosiseffectsinhalation

Outcome Measures

Primary Outcomes (1)

  • Forearm blood flow in response to infused intra-arterial vasodilators

    6 hours post-exposure

Secondary Outcomes (5)

  • Arterial stiffness measured by applanation tonometry

    In the 1 hour following exposure

  • Thrombogenicity measured using the Badimon chamber - an ex-vivo model of thrombosis under conditions of continuous flow

    2 hours after the exposure

  • Exhaled nitric oxide - a marker of pulmonary inflammation

    1 hour & 6 hours after exposure

  • Endogenous fibrinolytic capacity - measured as net release of t-PA in response to infused bradykinin

    6 hours after exposure

  • Biochemical markers of systemic inflammation

    Baseline, 2, 6 & 24 hours

Study Arms (3)

1

EXPERIMENTAL

1 hour exposure to filtered air

Procedure: Forearm Venous Occlusion Plethysmography

2

EXPERIMENTAL

1 hour exposure to diesel exhaust (300mcg/m3)

Procedure: Forearm Venous Occlusion Plethysmography

3

EXPERIMENTAL

1 hour exposure to filtered diesel exhaust

Procedure: Forearm Venous Occlusion Plethysmography

Interventions

Forearm venous occlusion plethysmography with intra-arterial infusion of Acetylcholine (5-20mcg/min), bradykinin (30-300mcg/min), sodium nitroprusside (2-8mcg/min) and Verapamil (2-10 mcg/min) into non-dominant brachial artery

123

Eligibility Criteria

Age18 Years - 35 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy male volunteers

You may not qualify if:

  • Intercurrent illness
  • Smoking
  • Significant occupational exposure to air pollution
  • Regular medication usage

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Umeå University

Umeå, Västerbottens, SE-901 87, Sweden

Location

Related Publications (1)

  • Lucking AJ, Lundback M, Barath SL, Mills NL, Sidhu MK, Langrish JP, Boon NA, Pourazar J, Badimon JJ, Gerlofs-Nijland ME, Cassee FR, Boman C, Donaldson K, Sandstrom T, Newby DE, Blomberg A. Particle traps prevent adverse vascular and prothrombotic effects of diesel engine exhaust inhalation in men. Circulation. 2011 Apr 26;123(16):1721-8. doi: 10.1161/CIRCULATIONAHA.110.987263. Epub 2011 Apr 11.

MeSH Terms

Conditions

Heart DiseasesThrombosisRespiratory Aspiration

Condition Hierarchy (Ancestors)

Cardiovascular DiseasesEmbolism and ThrombosisVascular DiseasesRespiration DisordersRespiratory Tract DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Anders Blomberg, MD

    Umeå University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER

Study Record Dates

First Submitted

September 2, 2008

First Posted

September 3, 2008

Study Start

September 1, 2007

Primary Completion

February 1, 2008

Study Completion

February 1, 2008

Last Updated

September 5, 2008

Record last verified: 2008-09

Locations